Physician profile
Munib Aftab
NPI 1962835074
$2,662.72
in general payments reported to CMS, 2019-2025
19 companies · $1,003 in 2025
The $1,003 reported for 2025 was more than what a typical Rheumatology provider received nationally (typical 2025 total: $894).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $61.82 · 2022: $307 · 2023: $856 · 2024: $435 · 2025: $1,003.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,275 · Education: $19.25.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,274.72 |
| Education | $19.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $634.33 | 2022-2025 | Enbrel, Otezla, Tavneos |
| Abbvie INC. | $477.50 | 2021-2025 | Rinvoq, Skyrizi, Humira |
| Janssen Biotech, INC. | $283.03 | 2022-2025 | Tremfya |
| Ucb, INC. | $272.52 | 2022-2025 | Cimzia, Bimzelx |
| Novartis Pharmaceuticals Corporation | $213.51 | 2023-2025 | |
| Pfizer INC. | $152.85 | 2022-2024 | |
| Glaxosmithkline, LLC. | $114.78 | 2022-2025 | Benlysta |
| Sobi, INC | $107.58 | 2022-2024 | |
| Astrazeneca Pharmaceuticals LP | $76.08 | 2023-2025 | Saphnelo |
| Boehringer Ingelheim Pharmaceuticals, INC. | $66.04 | 2023 | Cyltezo, Ofev |
| Horizon Therapeutics Plc | $64.76 | 2022 | |
| Janssen Scientific Affairs, LLC | $35.81 | 2022 | |
| Organon LLC | $34.49 | 2023 | Renflexis, Hadlima |
| Sandoz INC. | $32.28 | 2023-2024 | Hyrimoz |
| Alexion Pharmaceuticals, INC. | $29.42 | 2022 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Pharmaceuticals Incorporated | $20.02 | 2023 | Zilretta |
| E.R. Squibb & Sons, L.L.C. | $19.02 | 2023 | Orencia |
| Fresenius Kabi USA, LLC | $16.06 | 2023 | |
| Mallinckrodt Hospital Products INC. | $12.64 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Munib Aftab listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.